Thus, substantial effort is being directed to the search for additional protein biomarkers which either individually or in combination with CA125 and other markers could enhance the sensitivity and specificity for detecting ovarian cancer at an earlier, more treatable stage. Here, MUC16 is linked to ovarian carcinoma.